Regeneron Pharmaceuticals, Inc

Biotechnology
REGN
$ 661 0.61
Share price
$ 73 bn
Market Cap
$ 67 bn
Enterprise Value

Carbon footprint

1.2 Ton
GHG emissions per $ 1 mln investment
0.04x the weighted average for S&P 500
FY2020
How is this calculated?
+1.1%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Regeneron Pharmaceuticals, Inc's GHG emissions (market-based) (Kt of CO2e)
Regeneron Pharmaceuticals, Inc's Carbon intensity (Tons per 1 USDm)

Regeneron Pharmaceuticals, Inc's carbon footprint

Regeneron Pharmaceuticals, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 81 Kt (+0.9/+1.1% y-o-y). At the sime time, carbon intensity plummeted to 9.5 t (-2.7 /-22.1% y-o-y).

Regeneron Pharmaceuticals, Inc's Scope 3 emissions skyrocketed to 769 Kt (+209/+37% y-o-y). The growth accelerated compared to the long-term upward trend (CAGR of +28% since 4Q'17).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...